ABSTRACT
Biofilm and hypha formation are central to virulence of the fungal pathogen Candida albicans. The G1 cyclin gene HGC1 is required for hypha formation under diverse in vitro and in vivo growth conditions. Hgc1 is required for disseminated infection and is a linchpin in the argument that hyphal morphogenesis itself is required for pathogenicity. We report here that HGC1 is dispensable for hypha formation during biofilm formation both in vitro, under strong inducing conditions, and in vivo, in a mouse oropharyngeal candidiasis model. These findings are validated with two or more C. albicans isolates. Systematic screening of overexpressed cyclin genes indicates that CCN1 and CLN3 can compensate partially for Hgc1 function during biofilm growth. This conclusion is also supported by the severity of the hgc1Δ/Δ ccn1Δ/Δ double mutant biofilm defect. Our results suggest that hypha formation in biofilm is accomplished by combined action of multiple cyclins, not solely by Hgc1.
KEYWORDS: biofilm, Candida, hyphae, regulation, virulence
INTRODUCTION
The opportunistic fungal pathogen Candida albicans is the primary cause of invasive candidiasis, with mortality rates of 30 to 40% (1). It colonizes and infects mucosal surfaces, organs, and tissues. In addition, C. albicans can form multicellular biofilm communities on tissues and implanted medical devices, evading host immunity and antifungal treatment (2).
C. albicans can grow in both yeast and filamentous forms. Yeast are unicellular ovoid-shaped cells that grow by budding. Filamentous forms include both pseudohyphae and hyphae. Pseudohyphae are ellipsoid cells with constrictions at the septation site, and hyphae are long parallel-sided cells with no such constriction (3). Hyphae grow by tip extension and emerge from a yeast cell upon induction as a highly polarized germ tube (3). Adherence of hyphae to human epithelial and endothelial cells enables invasion of host tissue (4, 5). Hypha formation is significant because it is required for both biofilm formation and virulence (5).
The hypha-associated gene HGC1 (hyphal specific G1 cyclin 1) encodes a cyclin with strongest similarity to the G1 family of cyclins and is indispensable for hyphal growth under many environmental conditions (6). Hgc1 associates with cyclin-dependent kinase Cdc28 to direct continuous growth at the hyphal tip (6) through phosphorylation of diverse effector proteins (7, 8). Like many genes required for hypha formation (9, 10), HGC1 is required for biofilm formation under some conditions (11, 12). Importantly, HGC1 is required for virulence in a disseminated infection model (6, 11). The virulence defect of an hgc1Δ/Δ mutant is a key element in the hypothesis that hyphal growth itself is required for virulence (7, 13).
There are two additional G1 cyclins in C. albicans, Cln3 and Ccn1. Cln3 is essential for yeast cell propagation (14–16) and functions as a negative regulator of hyphal morphogenesis (15–17). Specifically, repression of CLN3 expression under yeast growth conditions causes production of hyphal filaments (15, 16). Ccn1 is not essential for growth, but it is required for normal hyphal morphogenesis under some growth conditions, including solid medium or nutritionally poor medium (18, 19). While ccn1Δ/Δ mutants initiate hypha formation as efficiently as the respective wild-type (WT) strain, they revert to yeast-form growth after prolonged incubation, when the wild-type strain continues to produce hyphae (20). Therefore, Ccn1 is considered to promote maintenance of hyphal growth but not initiation (19, 20).
Hyphae support virulence of C. albicans in many ways (9). Prominent among these is biofilm formation, which depends upon hypha formation in almost all contexts investigated (9, 10). The determinants of biofilm formation have been characterized extensively (9, 10). Biofilm formation depends upon Hgc1 in a well-established assay system with Spider medium (12). However, imaging was not used in that study to determine whether the hgc1Δ/Δ mutant grew as hyphae in the nominal biofilm that was produced. In fact, the authors pointed out that the precise role of Hgc1 in biofilm formation was uncertain (12).
In recent studies, we have sought to define the genetic determinants of biofilm formation among multiple C. albicans clinical isolates (21, 22). We have found that biofilm determinants vary considerably from strain to strain (21, 22). Our studies thus far have examined the regulatory network that controls expression of hypha-associated genes like HGC1. Because Hgc1 is a downstream target of the network, and because it has defined mechanistic roles in hyphal morphogenesis (7, 13), we anticipated that it would be required for biofilm formation in all C. albicans strains. The simple rationale for our study led us to a result that we consider astonishing: an hgc1Δ/Δ mutation does not abolish hypha formation under biofilm growth conditions. We document the finding in several C. albicans strains and in two distinct biofilm models. Follow-up analysis argues that G1 cyclins Ccn1 and Cln3 contribute to hyphal development and biofilm growth and that they may overcome the absence of Hgc1 to promote hypha formation in the context of biofilm growth.
RESULTS
Natural variation in the impact of Hgc1 on pathogenicity traits.
We constructed hgc1Δ/Δ mutants in five clinical isolates (21, 23, 24): SC5314 (clade 1), P76067 (clade 2), P57055 (clade 3), GC75 (clade 4), and 19F (clade 1). SC5314, P76067, and GC75 undergo filamentation strongly under several growth conditions, while P57055 and 19F undergo filamentation weakly (see below and references 21 and 23).
Wild-type and mutant strains were assayed for hypha formation under planktonic (nonbiofilm, free-living) growth conditions. In RPMI-plus-serum medium at 37°C, the wild-type strains all produced hyphae, though the extent of hypha formation varied (Fig. 1A and C). SC5314, P76067, and GC75 hgc1Δ/Δ mutants yielded predominantly pseudohyphae, and P57055 and 19F hgc1Δ/Δ mutants yielded mainly short germ tubes and yeast cells (Fig. 1A and C). Reconstituted derivatives of the hgc1Δ/Δ mutants, in which two copies of HGC1 from SC5314 were introduced at the native locus, regained the ability to form hyphae comparable to the respective wild-type strain (see Fig. S1 in the supplemental material). In Spider medium at 37°C, all wild-type strains except SC5314 produced hyphae less efficiently than in RPMI plus serum (Fig. 1B and D). SC5314 and P76067 hgc1Δ/Δ mutants yielded pseudohyphae and yeast cells, and P57055, GC75, and 19F hgc1Δ/Δ mutants yielded mainly yeast cells (Fig. 1B and D). These observations indicate that overall filamentation of each mutant strain varies in proportion to filamentation of the respective wild-type strain. In every case, though, the hgc1Δ/Δ mutation prevented detectable formation of hyphae. These results support the current understanding of Hgc1 function and extend that understanding to multiple C. albicans isolates.
Hgc1 is required for pathogenicity in systemic mouse and zebrafish infection models (6, 25). For many C. albicans mutants, defects in systemic infection capacity correlate with defects in endothelial cell damage capacity (26–28). Therefore, we tested the five wild-type, hgc1Δ/Δ, and complemented strains for ability to damage human endothelial cells. Strains SC5314 and GC75 inflicted more damage than the other wild-type strains (Fig. 2); the corresponding hgc1Δ/Δ mutants exhibited reduced damage ability, which was restored by complementation (Fig. 2). The P76067, P57055, and 19F hgc1Δ/Δ mutants trended toward a reduction in damage compared to the wild-type strains, but the differences were not statistically significant. These results indicate that hgc1Δ/Δ mutations can cause endothelial cell damage defects; detection of this phenotype may depend upon strong damage ability of the wild-type strain. Because hyphal defects are associated with endothelial cell damage defects (4, 27), these results are consistent with current understanding of Hgc1 function.
Dispensability of Hgc1 for biofilm formation.
In prior studies, Hgc1 was found to be required for biofilm formation (12, 29). We sought to assay the impact of hgc1Δ/Δ mutations on biofilm formation in multiple strain backgrounds. We used RPMI-plus-serum medium at 37°C, a condition that induces hyphae strongly and promotes biofilm formation by all wild-type strains in this study (Fig. 3). Under our conditions, SC5314, P76067, and GC75 produced biofilm depth of ~60 to 90 μm, while P57055 and 19F produced biofilm depth of 25 to 60 μm. In all strain backgrounds, hgc1Δ/Δ mutants produced biofilm, though depth was slightly reduced compared to the respective wild-type strain (Fig. 3). Quantitative XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt] dye reduction assays confirmed that hgc1Δ/Δ mutants had reduced biofilm biomass (Fig. S2). These results indicate that Hgc1 is required for normal biofilm biomass in all five strains examined. However, under our conditions, hgc1Δ/Δ mutants are clearly capable of biofilm formation.
The hgc1Δ/Δ mutant biofilms had a striking structural feature. Long, highly polarized hyphae were present in mutant biofilms in the SC5314, P76067, and GC75 strain backgrounds (Fig. 4). In contrast, filaments in the hgc1Δ/Δ mutant biofilms of P57055 and 19F, which were less numerous, had evident constrictions like pseudohyphae. The ability of hgc1Δ/Δ mutants to produce long hyphae conflicts with current understanding of Hgc1 function (7, 13, 17).
Given that hgc1Δ/Δ mutants produce hyphae during biofilm growth in vitro, we sought to extend our studies to a biofilm-based infection model, the oral mucosal infection model (30–32). We used SC5314, the type strain, as well as GC75, which is highly virulent in a mouse systemic infection model (24). Immunosuppressed mice were inoculated orally, and fungal burdens were assayed at 5 days postinfection. The two wild-type strains produced similar fungal burdens (Fig. 5A); both hgc1Δ/Δ mutants had slightly reduced fungal burdens (Fig. 5A). Histopathological examination of infected tongues revealed that hyphae of wild-type SC5314 invaded the entire tongue epithelium. The corresponding hgc1Δ/Δ mutant also formed hyphae, though invasion was more superficial (Fig. 5B). The wild-type GC75 produced short hyphae and caused only superficial invasion in this model (Fig. 5B). The corresponding hgc1Δ/Δ mutant behaved similarly (Fig. 5B). We conclude that Hgc1 is required for maximal virulence during oral infection in both strains. However, Hgc1 is not required for hypha formation in the oral environment. This observation conflicts with the current understanding of the Hgc1 function (7, 13, 17). In addition, the finding that hgc1Δ/Δ mutants of two different genetic backgrounds form hyphae in this infection model indicates that hypha formation in the absence of Hgc1 is not unique to one strain background.
Contribution of G1 cyclins Ccn1 and Cln3 to biofilm growth.
We hypothesized that the other G1 cyclin genes CCN1 and CLN3 may compensate for HGC1 function under biofilm growth conditions. We first investigated cyclin gene function through overexpression in the SC5314 wild-type and hgc1Δ/Δ strains. To overexpress the cyclin genes, we constructed a panel of heterozygous strains, each with one allele of a cyclin gene fused to the RBT5 promoter (33). The RBT5 promoter is repressed under the iron-sufficient growth conditions used for routine growth (33), thus minimizing potential for overexpression-related growth defects. The promoter is induced when strains are grown under iron-limited conditions, such as RPMI medium, and is similar in strength to the TDH3 promoter (33). In order to detect possible improvement of biofilm growth, we used RPMI medium without serum, in which hgc1Δ/Δ mutants produce more pseudohyphae than in RPMI plus serum. Wild-type SC5314 and its overexpression strains yielded biofilms of similar depth, though overexpression of CCN1 and CLN3 caused slightly increased biofilm volume (Fig. S4 and S6). Overexpression of CCN1 and CLN3 in the hgc1Δ/Δ mutant increased both biofilm depth and volume (Fig. 6A, B, and C). These observations argue that G1 cyclins Ccn1 and Cln3 can compensate for loss of Hgc1 function during biofilm growth. We extended this conclusion with cell unit length measurements (Fig. 6D). The hgc1Δ/Δ mutant grew predominantly as pseudohyphae with less polarized hyphal filaments in RPMI medium (Fig. 6D). Increased expression of either CCN1 or CLN3 in the hgc1Δ/Δ background significantly increased the cell unit length (Fig. 6D and E). The features of both biofilm and cell units indicate that the G1 cyclin genes CCN1 and CLN3 contribute to hyphal growth in the absence of Hgc1.
Genetic interaction of HGC1 and CCN1 during biofilm growth.
The hypothesis that G1 cyclins have shared function under biofilm conditions predicts that deletion of G1 cyclin genes in the hgc1Δ/Δ background may increase the severity of its biofilm defect. CLN3 is essential for C. albicans growth (14, 16, 34); CCN1 is not. We constructed a homozygous hgc1Δ/Δ ccn1Δ/Δ mutant in the SC5314 background and compared single and double mutant biofilm growth in RPMI-plus-serum medium at 37°C for 24 h. The ccn1Δ/Δ mutant produced biofilm (110-μm depth and 41-mm3 volume) comparable to that of the wild-type strain (104-μm depth and 39-mm3 volume) (Fig. 7A, B, and C). However, biofilm growth of the hgc1Δ/Δ ccn1Δ/Δ mutant (45-μm depth and 25-mm3 volume) was significantly reduced compared to that of the hgc1Δ/Δ mutant (79-μm depth and 31-mm3 volume) (Fig. 7A, B, and C). hgc1Δ/Δ and hgc1Δ/Δ ccn1Δ/Δ mutants did not show significant differences in hyphal growth under these conditions (Fig. S3). Because deletion of the two cyclin genes causes a more severe defect than deletion of either gene alone, we conclude that HGC1 and CCN1 contribute independently to biofilm formation.
Screen of cyclin genes for potential regulators of hyphal growth.
Our results argue that all three G1 cyclins contribute to hyphal growth under infection-relevant conditions. This prompted us to investigate the role of other cyclin genes in hyphal development. There are 6 other prospective cyclin genes in the C. albicans genome; they encode G2 cyclins (CLB2 and CLB4) and PHO85 cyclins (CLG1 and PCL1, -2, -5, and -7). We tested possible improvement of biofilm formation by overexpression of each gene in the SC5314 wild-type and hgc1Δ/Δ strains. In each strain one allele of a cyclin gene was fused to the RBT5 promoter (33). We assayed the strains for biofilm growth under conditions that magnify the hgc1Δ/Δ defect (RPMI medium for 24 h). SC5314 WT and its six cyclin-overexpression strains promoted biofilm growth of similar depth; however, overexpression of PCL1 significantly increased volume compared to the WT (Fig. S4A, Fig. S5, and Fig. S6). Overexpression of 6 cyclin genes did not rescue the biofilm growth defect of the hgc1Δ/Δ mutant (Fig. S4B, C, and D), though increased expression of PCL1 and PCL7 in the hgc1Δ/Δ background increased the cell unit length (Fig. S4E and F). Therefore, these additional cyclin genes cannot rescue the hgc1Δ/Δ biofilm defect. These results indicate that the functional interaction of Hgc1, Ccn1, and Cln3 under biofilm conditions is specific for G1 cyclins.
DISCUSSION
Biofilm growth of C. albicans requires hypha formation under virtually all circumstances (2, 9, 10). The G1 cyclin gene HGC1 is well established as a central driver of hyphal development in C. albicans (7, 17). HGC1 was shown to be required for biofilm formation by otherwise wild-type strains in one study (12), and it seemed very reasonable that the hgc1Δ/Δ mutation caused a biofilm defect due to its hyphal defect. Our results here indicate that hgc1Δ/Δ mutants produce hyphae during biofilm growth in vitro, under strong inducing conditions, and in vivo, in an oral infection model. Gene overexpression and double mutant analysis argues that two other G1 cyclin genes, CCN1 and CLN3, can compensate partially for the absence of HGC1 function.
Planktonic cell Hgc1 function.
Prior studies revealed that some hyphal regulatory mutations have strain-dependent phenotypic impact (21). For example, bcr1Δ/Δ and ume6Δ/Δ mutations block hypha formation in some strains but not others (21). For hgc1Δ/Δ mutations, the severity of mutant phenotypes also varies among strains. In some cases, variation in the impact of hgc1Δ/Δ mutations reflects the strength of the corresponding wild-type phenotype. The clearest example is endothelial cell damage ability, where hgc1Δ/Δ mutations cause a significant defect only in high-damage strains. The extent of planktonic hyphal morphogenesis defects also followed this principle. In RPMI plus serum, hgc1Δ/Δ mutants of the strong hyphal formers SC5314, P76067, and GC75 yielded abundant pseudohyphae; hgc1Δ/Δ mutants of the weaker hyphal formers P57055 and 19F yielded few pseudohyphae and more abundant yeast and unclassifiable cells. Given that hgc1Δ/Δ mutants cause a planktonic hyphal defect in all strain backgrounds, our observations argue that Hgc1 is of uniformly critical importance for hypha formation under the planktonic growth conditions tested.
Biofilm cell Hgc1 function.
We found two conditions under which hgc1Δ/Δ mutants produce hyphae. One condition was growth in the mouse oral infection model. Filaments were evident after 5 days of infection with hgc1Δ/Δ mutants of SC5314 and GC75. A second such condition was during biofilm growth in vitro. The hgc1Δ/Δ mutants of three strains produced biofilm with abundant long filaments. In this case, the filaments were sufficiently adherent to yield biofilms of considerable depth. These observations indicate that hypha formation can occur in the absence of Hgc1 under infection-relevant conditions.
How may biofilm growth conditions alter cyclin regulation of hypha formation? The high density of a biofilm community favors exchange of small molecules, including quorum-sensing signals and metabolic waste products (35). Sharing of extracellular vesicles also has a prominent impact on the biofilm phenotype (36). A simple hypothesis is that exchange of small molecules or vesicles rebalances or reconfigures cyclin activities, such that Ccn1 and Cln3 are more capable of assuming the function of Hgc1.
Polarized growth of dying hgc1Δ/Δ mutants was reported previously by Chen et al. (37). Arrest of DNA synthesis, achieved with hydroxyurea treatment, induced formation of polarized projections that resemble pseudohyphae by both wild-type and hgc1Δ/Δ mutant strains. This situation seems distinct from our observations here in that we found hyphae produced during growth, not during terminal cell cycle arrest. However, an interesting possibility is that the mechanism revealed by S phase arrest is utilized naturally under biofilm growth conditions, in keeping with the suggestion of Chen et al. (37).
MATERIALS AND METHODS
Media.
Strains were routinely grown on YPD (2% Bacto peptone, 2% dextrose, 1% yeast extract). Transformants were selected on YPD plus 400 μg/mL nourseothricin or complete synthetic medium (CSM) (2% dextrose, 1.7% Difco yeast nitrogen base with ammonium sulfate and auxotrophic supplements). For phenotypic assays, strains were grown in liquid RPMI 1640 medium (Sigma-Aldrich), adjusted to pH 7.4 and supplemented with 10% fetal bovine serum (Atlanta Biologicals), and Spider medium (nutrient broth, mannitol [Sigma M9647], K2HPO4, pH adjusted to 7.2 with NaOH).
Strains.
C. albicans strains used in this study are listed in Table S1 in the supplemental material.
Primers and plasmid construction.
Plasmids and primers are listed in Tables S2 and S3, respectively. The full-length open reading frame (ORF) of the HGC1 allele along with the promoter (1.3 kb) and terminator region (690 bp) was amplified from SC5314 genomic DNA using primers HGC1cloning F1 and HGC1cloning R1. The PCR product was then cloned in the pGEM-2T vector and sequenced to get the plasmid pGEM-HGC1.
Construction of HGC1 deletion mutants.
Both alleles of HGC1 were deleted in his1Δ/Δ derivatives of clinical isolates using the transient CRISPR-Cas9 system (38). Briefly, transformations included DNA cassettes (Cas9 DNA, HGC1 single guide RNA [sgRNA] DNA, NAT1-2 sgRNA DNA) and the hgc1Δ::r1HIS1r1 repair template. The HGC1 sgRNA DNA cassette was amplified using split-joint PCR with the primers sgRNA/F HGC1 and SNR52/R HGC1. The hgc1Δ::r1HIS1r1 repair template was generated in two parts per reference 39, using plasmid pMH01 with primers HIS1 CRIME/F and HGC1 del rHIS1r KpnI/R, and plasmid pMH02 with primers HGC1 del rHIS1r SapI/F and HIS1 CRIME/R. Transformants were selected on CSM-His medium and replica plated onto YPD-plus-nourseothricin plates to screen for nourseothricin sensitivity. PCR genotyping was done with primers HGC1 check up/F and HGC1 check int/R for the absence of the HGC1 ORF. Confirmation PCR with primers HGC1 check up/F and CdHIS1 Check Int/R verified integration of HIS1 at the hgc1Δ locus.
Reconstituted strains had two copies of the SC5314 HGC1 allele replacing the two hgc1Δ alleles via the concatemer assembly method (21). First, an HGC1 cassette was amplified from plasmid pGEM-HGC1 using primers HGC1cloning F1 and HGC1 3′R1-pNAT5′/R, containing concatenating homology to the NAT1 marker. Then, the NAT1 marker was amplified from pNAT using pNATF and pNAT 3′R-HGC1down/R1. The HGC1-containing cassette, corresponding NAT1 marker, and r1 sgRNA DNA cassette were transformed into the hgc1Δ/Δ deletion mutant strains in all clinical isolate backgrounds, using a similar method as described earlier (37). Homozygosity at the HGC1 locus was determined using the presence or absence of an r1 scar (39, 40) and using PCR genotyping with the HGC1 check up/F and r1 check int/R primers.
Construction of PRBT5 cassettes of cyclin genes.
To generate heterozygous strains overexpressing cyclin genes CCN1, CLN3, CLG1, PCL1, PCL2, PCL5, PCL7, CLB2, and CLB4, a PRBT5 cassette containing flanking homology to the gene upstream promoter region was amplified using primer sets CCN1OE F and CCN1OE R, CLN3OE F and CLN3OE R, CLG1OE F and CLG1OE R, PCL1OE F and PCL1OE R, PCL2OE F and PCL2OE R, PCL5OE F and PCL5OE R, PCL7OE F and PCL7OE R, CLB2OE F and CLB2OE R, and CLB4OE F and CLB4OE R, from plasmid pTH10 (33).
The sgRNA cassettes for the 5′ regions of each gene were generated using split-joint PCR using primers sgRNA/F CCN1P-1 and SNR52/R CCN1P-1, sgRNA/F CLN3P-1 and SNR52/R CLN3P-1, sgRNA/F CLG1P-1 and SNR52/R CLG1P-1, sgRNA/F PCL1P-1 and SNR52/R PCL1P-1, sgRNA/F PCL2P-1 and SNR52/R PCL2P-1, sgRNA/F PCL5P-1 and SNR52/R PCL5P-1, sgRNA/F PCL7P-1 and SNR52/R PCL7P-1, sgRNA/F CLB2P-1 and SNR52/R CLB2P-1, and sgRNA/F CLB4P-1 and SNR52/R CLB4P-1. The SC5314 WT and SC5314 hgc1Δ mutant strains were then transformed with 3 μg of the respective PRBT5 cassette and 1 μg of sgRNA DNA cassette along with 1 μg of Cas9.
Transformants were selected on YPD-plus-nourseothricin plates for the resistant phenotype and were genotyped by PCR using primers CCN1 CHF and CCN1 CHR for the presence of one copy of the native CCN1 promoter and CCN1 FCHF and NAT CHR for the presence of the PRBT5 cassette in the target gene promoter region. Similarly, other gene constructs were genotyped using respective primer sets (Table S3).
Construction of CCN1 deletion mutants.
Both alleles of CCN1 were deleted in the SC5314 wild type and its hgc1Δ/Δ mutant strain using a transient CRISPR-Cas9 system (38). Briefly, transformations included DNA cassettes (Cas9 DNA and CCN1-3 sgRNA DNA) and the ccn1Δ::rNATr repair template. The CCN1-3 sgRNA DNA cassette was amplified using split-joint PCR with the primers sgRNA/F CCN1-3 and SNR52/R CCN1-3. The ccn1Δ::rNATr repair template was generated in two parts as per reference 39, using plasmid pMH05 with primers NAT CRIME/F and CCN1 del rNATrXmaI/R, and plasmid pMH06 with primers CCN1 del rNATrBamHI/F and NAT CRIME/R. Transformants were selected on YPD-plus-nourseothricin plates to screen for nourseothricin resistance. PCR genotyping was done with primers CCN1 CHF and CCN1 CHR for the absence of the CCN1 ORF. Confirmation PCR with primers CCN1 CHF and NAT CHR verified integration of NAT at the ccn1Δ locus.
Filamentation assays and imaging.
Hypha formation was assayed essentially as previously described (21). Calcofluor-stained cells were then imaged with a Zeiss fluorescence microscope.
Biofilm growth and imaging.
To assay biofilm formation in a 96-well plate (Greiner 96-well plate; catalog no. 655090), strains were inoculated to an optical density at 600 nm (OD600) of 0.5 from overnight cultures into 100 μL of prewarmed RPMI with 10% fetal bovine serum (FBS) and RPMI. First, the cells were incubated in a shaker incubator at 37°C for 90 min with mild shaking (60 rpm) to allow adherence, and then each well was gently washed twice with phosphate-buffered saline (PBS). Next, 100 μL of prewarmed RPMI with 10% FBS or RPMI was added into each well, and cells were allowed to form biofilm in a shaker incubator with 60 rpm at 37°C for 24 h. At that time, the medium was discarded from each well, and biofilms were fixed by incubation with 100 μL of 4% formaldehyde in PBS solution for 1 h and then gently washed twice with PBS. Biofilms were stained with calcofluor white (200 μg/mL in PBS) overnight at room temperature (RT) with mild shaking (60 rpm), and then each well was gently washed twice with PBS. To clarify biofilms in the 96-well plates, we used 100% TDE (thiodiethanol), which has a refractive index of 1.521. We removed the PBS from each well and added 100 μL of 50% TDE in PBS. We incubated the 96-well plate at room temperature for an hour and then removed the solution from each well. Finally, 100 μL of 100% TDE solution was added to the wells and incubated at RT for an hour, when the clarified biofilm was transparent. The biofilms for hgc1Δ/Δ mutant strains (grown in RPMI with 10% FBS) were imaged using a Zeiss Axiovert 200 microscope with a Zeiss 25× 0.8-numerical-aperture (NA) multi-immersion objective. The biofilms for strains overexpressing cyclin genes and CCN1 deletion were imaged using a Keyence BZ-X800E fluorescence microscope.
Biofilm image processing.
Optical sections of the biofilms were collected in several series of planes at an 0.45- or 0.85-μm step size. The stacks were concatenated and processed using Fiji software (41). The images were processed using the Background Subtract plugin. The side view projection images were obtained by reslicing the stack and using the maximum intensity Z-projection. The scale of the stacked side view images was adjusted based on the objective used for the imaging. The biofilm depth measurements are obtained from the side view projection images. The biofilm volume was measured from the stacked biofilm image. The threshold value for the image was selected based on the intensity of the pixels to separate the pixels of interest from the background surface. The macro code runs through each image in the stack to sum the area measurements. It further multiplies this sum by the depth of each slice to calculate the volume. Overall, this analysis measures the total volume of the pixels per area parallel to the background surface that has an intensity greater than a specified threshold value.
Endothelial cell damage assay.
The extent of the endothelial cell damage caused by the different strains of C. albicans was measured using the previously described 51Cr release assay (28, 42). The inoculum was 4 × 104 organisms per well of endothelial cells. Each assay was performed in triplicate on three separate occasions.
Biofilm quantification by XTT assay.
The quantification of biofilm growth was done using an XTT metabolic assay (43). Briefly, XTT (Sigma-Aldrich) was freshly prepared as a saturated solution in PBS (1 mg/mL). Before use, the menadione solution was prepared in acetone and added to the XTT to a final concentration of 1 μM. Strains were inoculated from overnight cultures to an OD600 of 1.67 into 1 mL of prewarmed RPMI with 10% serum. From this culture, 2 μL was inoculated into 100 μL prewarmed RPMI with 10% serum in a 96-well plate. Each strain was done in triplicate. The final OD600 of the culture was 0.033 (~106 cells). The plate was incubated for 90 min at 37°C in a shaking incubator (60 rpm) and then washed with PBS. After that, 100 μL of prewarmed RPMI with 10% serum was added and then incubated at 37°C for 24 h in a shaking incubator. After washing with PBS, 100 μL of XTT-menadione solution was added and incubated at 37°C for 1 h. The solutions were transferred into a new 96-well plate, and OD492 was measured in each well using a plate reader.
Mouse model of oropharyngeal candidiasis.
C. albicans strains were tested for virulence in the mouse model of oropharyngeal candidiasis (OPC) described previously (44). Briefly, male BALB/c mice were immunosuppressed with cortisone acetate (225 mg/kg of body weight; Sigma-Aldrich) administered every other day, starting at day −1 relative to infection. The mice were inoculated by placing a calcium alginate swab saturated with C. albicans blastospores sublingually for 75 min. Mice were sacrificed after 5 days of infection. The tongues were harvested, weighed, and cut in half. One half was weighed and homogenized for quantitative culture, and the other half was processed for histopathological analysis.
Software.
Images were arranged or adjusted using Fiji software. All statistical analyses were carried out using GraphPad Prism, version 8.4.2.
ACKNOWLEDGMENTS
We thank Max Kuhr for exceptional lab management and technical support and Marilyn Gao for assistance with figure organization. We are grateful to Carol A. Woolford, Eunsoo Do, Katherine Lagree, Yinhe Mao, and Max V. Cravener for many helpful discussions and comments on the manuscript.
Contributor Information
Aaron P. Mitchell, Email: Aaron.Mitchell@uga.edu.
Yong-Sun Bahn, Yonsei University.
REFERENCES
- 1.Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–S13. doi: 10.1016/j.amjmed.2011.11.001. [DOI] [PubMed] [Google Scholar]
- 2.Cavalheiro M, Teixeira MC. 2018. Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne) 5:28. doi: 10.3389/fmed.2018.00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat Rev Microbiol 9:737–748. doi: 10.1038/nrmicro2636. [DOI] [PubMed] [Google Scholar]
- 4.Filler SG, Sheppard DC. 2006. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2:e129. doi: 10.1371/journal.ppat.0020129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Noble SM, Gianetti BA, Witchley JN. 2017. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol 15:96–108. doi: 10.1038/nrmicro.2016.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zheng X, Wang Y, Wang Y. 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 23:1845–1856. doi: 10.1038/sj.emboj.7600195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang Y. 2016. Hgc1-Cdc28-how much does a single protein kinase do in the regulation of hyphal development in Candida albicans? J Microbiol 54:170–177. doi: 10.1007/s12275-016-5550-9. [DOI] [PubMed] [Google Scholar]
- 8.Xie JL, Qin L, Miao Z, Grys BT, Diaz JC, Ting K, Krieger JR, Tong J, Tan K, Leach MD, Ketela T, Moran MF, Krysan DJ, Boone C, Andrews BJ, Selmecki A, Ho Wong K, Robbins N, Cowen LE. 2017. The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation. Nat Commun 8:499. doi: 10.1038/s41467-017-00547-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Basso V, d’Enfert C, Znaidi S, Bachellier-Bassi S. 2019. From genes to networks: the regulatory circuitry controlling Candida albicans morphogenesis. Curr Top Microbiol Immunol 422:61–99. doi: 10.1007/82_2018_144. [DOI] [PubMed] [Google Scholar]
- 10.Rodriguez DL, Quail MM, Hernday AD, Nobile CJ. 2020. Transcriptional circuits regulating developmental processes in Candida albicans. Front Cell Infect Microbiol 10:605711. doi: 10.3389/fcimb.2020.605711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, Villar CC, Lopez-Ribot JL, Kadosh D. 2013. Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms. Eukaryot Cell 12:224–232. doi: 10.1128/EC.00163-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lin CH, Kabrawala S, Fox EP, Nobile CJ, Johnson AD, Bennett RJ. 2013. Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans. PLoS Pathog 9:e1003305. doi: 10.1371/journal.ppat.1003305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chow EWL, Pang LM, Wang Y. 2021. From Jekyll to Hyde: the yeast-hyphal transition of Candida albicans. Pathogens 10:859. doi: 10.3390/pathogens10070859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP. 2002. Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162:1573–1581. doi: 10.1093/genetics/162.4.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bachewich C, Whiteway M. 2005. Cyclin Cln3p links G1 progression to hyphal and pseudohyphal development in Candida albicans. Eukaryot Cell 4:95–102. doi: 10.1128/EC.4.1.95-102.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chapa y Lazo B, Bates S, Sudbery P. 2005. The G1 cyclin Cln3 regulates morphogenesis in Candida albicans. Eukaryot Cell 4:90–94. doi: 10.1128/EC.4.1.90-94.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hossain S, Lash E, Veri AO, Cowen LE. 2021. Functional connections between cell cycle and proteostasis in the regulation of Candida albicans morphogenesis. Cell Rep 34:108781. doi: 10.1016/j.celrep.2021.108781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sinha I, Wang YM, Philp R, Li CR, Yap WH, Wang Y. 2007. Cyclin-dependent kinases control septin phosphorylation in Candida albicans hyphal development. Dev Cell 13:421–432. doi: 10.1016/j.devcel.2007.06.011. [DOI] [PubMed] [Google Scholar]
- 19.Bishop A, Lane R, Beniston R, Chapa-y-Lazo B, Smythe C, Sudbery P. 2010. Hyphal growth in Candida albicans requires the phosphorylation of Sec2 by the Cdc28-Ccn1/Hgc1 kinase. EMBO J 29:2930–2942. doi: 10.1038/emboj.2010.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Loeb JD, Sepulveda-Becerra M, Hazan I, Liu H. 1999. A G1 cyclin is necessary for maintenance of filamentous growth in Candida albicans. Mol Cell Biol 19:4019–4027. doi: 10.1128/MCB.19.6.4019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Huang MY, Woolford CA, May G, McManus CJ, Mitchell AP. 2019. Circuit diversification in a biofilm regulatory network. PLoS Pathog 15:e1007787. doi: 10.1371/journal.ppat.1007787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Do E, Cravener MV, Huang MY, May G, McManus CJ, Mitchell AP. 2022. Collaboration between antagonistic cell type regulators governs natural variation in the Candida albicans biofilm and hyphal gene expression network. mBio 13:e0193722. doi: 10.1128/mbio.01937-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hirakawa MP, Martinez DA, Sakthikumar S, Anderson MZ, Berlin A, Gujja S, Zeng Q, Zisson E, Wang JM, Greenberg JM, Berman J, Bennett RJ, Cuomo CA. 2015. Genetic and phenotypic intra-species variation in Candida albicans. Genome Res 25:413–425. doi: 10.1101/gr.174623.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wu W, Lockhart SR, Pujol C, Srikantha T, Soll DR. 2007. Heterozygosity of genes on the sex chromosome regulates Candida albicans virulence. Mol Microbiol 64:1587–1604. doi: 10.1111/j.1365-2958.2007.05759.x. [DOI] [PubMed] [Google Scholar]
- 25.Chao CC, Hsu PC, Jen CF, Chen IH, Wang CH, Chan HC, Tsai PW, Tung KC, Wang CH, Lan CY, Chuang YJ. 2010. Zebrafish as a model host for Candida albicans infection. Infect Immun 78:2512–2521. doi: 10.1128/IAI.01293-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Phan QT, Belanger PH, Filler SG. 2000. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68:3485–3490. doi: 10.1128/IAI.68.6.3485-3490.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sanchez AA, Johnston DA, Myers C, Edwards JE, Jr, Mitchell AP, Filler SG. 2004. Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 72:598–601. doi: 10.1128/IAI.72.1.598-601.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, Thompson A, Liu Y, Dongari-Bagtzoglou A, Edgerton M, Filler SG. 2010. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog 6:e1001181. doi: 10.1371/journal.ppat.1001181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Carlisle PL, Kadosh D. 2010. Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclin-related protein. Eukaryot Cell 9:1320–1328. doi: 10.1128/EC.00046-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. 2009. Characterization of mucosal Candida albicans biofilms. PLoS One 4:e7967. doi: 10.1371/journal.pone.0007967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Solis NV, Wakade RS, Glazier VE, Ollinger TL, Wellington M, Mitchell AP, Filler SG, Krysan DJ. 2022. Systematic genetic interaction analysis identifies a transcription factor circuit required for oropharyngeal candidiasis. mBio 13:e0344721. doi: 10.1128/mbio.03447-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tsui C, Kong EF, Jabra-Rizk MA. 2016. Pathogenesis of Candida albicans biofilm. Pathog Dis 74:ftw018. doi: 10.1093/femspd/ftw018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mao Y, Solis NV, Sharma A, Cravener MV, Filler SG, Mitchell AP. 2022. Use of the iron-responsive RBT5 promoter for regulated expression in Candida albicans. mSphere 7:e0030522. doi: 10.1128/msphere.00305-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Segal ES, Gritsenko V, Levitan A, Yadav B, Dror N, Steenwyk JL, Silberberg Y, Mielich K, Rokas A, Gow NAR, Kunze R, Sharan R, Berman J. 2018. Gene essentiality analyzed by in vivo transposon mutagenesis and machine learning in a stable haploid isolate of Candida albicans. mBio 9:e02048-18. doi: 10.1128/mBio.02048-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mukherjee S, Bassler BL. 2019. Bacterial quorum sensing in complex and dynamically changing environments. Nat Rev Microbiol 17:371–382. doi: 10.1038/s41579-019-0186-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Heredia M, Andes D. 2021. Contributions of extracellular vesicles to fungal biofilm pathogenesis. Curr Top Microbiol Immunol 432:67–79. doi: 10.1007/978-3-030-83391-6_7. [DOI] [PubMed] [Google Scholar]
- 37.Chen C, Zeng G, Wang Y. 2018. G1 and S phase arrest in Candida albicans induces filamentous growth via distinct mechanisms. Mol Microbiol 110:191–203. doi: 10.1111/mmi.14097. [DOI] [PubMed] [Google Scholar]
- 38.Min K, Ichikawa Y, Woolford CA, Mitchell AP. 2016. Candida albicans gene deletion with a transient CRISPR-Cas9 system. mSphere 1:e00130-16. doi: 10.1128/mSphere.00130-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Huang MY, Mitchell AP. 2017. Marker recycling in Candida albicans through CRISPR-Cas9-induced marker excision. mSphere 2:e00050-17. doi: 10.1128/mSphere.00050-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Huang MY, Woolford CA, Mitchell AP. 2018. Rapid gene concatenation for genetic rescue of multigene mutants in Candida albicans. mSphere 3:e00169-18. doi: 10.1128/mSphere.00169-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Filler SG, Yeaman MR, Sheppard DC. 2005. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 41(Suppl 3):S208–S212. doi: 10.1086/430000. [DOI] [PubMed] [Google Scholar]
- 43.Nett JE, Cain MT, Crawford K, Andes DR. 2011. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol 49:1426–1433. doi: 10.1128/JCM.02273-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Solis NV, Filler SG. 2012. Mouse model of oropharyngeal candidiasis. Nat Protoc 7:637–642. doi: 10.1038/nprot.2012.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.